What is Augmentin 7:1 and How is Dosing Calculated?
Augmentin 7:1 refers to a specific ratio formulation of amoxicillin to clavulanic acid (7 parts amoxicillin to 1 part clavulanate), though this ratio is less commonly used than the 14:1 high-dose pediatric formulation that has become the standard for treating resistant respiratory infections.
Understanding Augmentin Ratios
The ratio in Augmentin formulations represents the proportion of amoxicillin to clavulanic acid. Different ratios exist because:
- Clavulanic acid is a beta-lactamase inhibitor that protects amoxicillin from bacterial enzymes but causes more gastrointestinal side effects
- Higher ratios allow more amoxicillin (for better bacterial killing) while limiting clavulanate exposure (to reduce side effects)
- The original formulation was 4:1, followed by 7:1, and now the preferred high-dose pediatric formulation is 14:1 1
The Math Behind High-Dose Augmentin (14:1 Ratio)
Pediatric Dosing Calculation
For children with acute bacterial rhinosinusitis or otitis media, the recommended high-dose regimen is 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate, divided into two doses 1.
Step-by-step calculation:
- Calculate total daily amoxicillin dose: 90 mg/kg/day
- Calculate total daily clavulanate dose: 6.4 mg/kg/day
- Verify the ratio: 90 ÷ 6.4 = 14:1 ratio
- Divide into two doses per day (given every 12 hours)
Example for a 20 kg child:
- Amoxicillin: 90 mg/kg × 20 kg = 1,800 mg/day (900 mg per dose, twice daily)
- Clavulanate: 6.4 mg/kg × 20 kg = 128 mg/day (64 mg per dose, twice daily)
- This maintains the 14:1 ratio
Adult Dosing
For adults, high-dose amoxicillin/clavulanate is defined as 4 g of amoxicillin with 250 mg of clavulanate per day 1. This creates a 16:1 ratio and uses a modified-release mechanism.
Clinical Context: When to Use High-Dose Formulations
Use the 14:1 high-dose pediatric formulation (90/6.4 mg/kg/day) for:
- Children with moderate disease or recent antibiotic use (within 4-6 weeks) 1
- Areas with high prevalence of penicillin-resistant Streptococcus pneumoniae
- Recurrent or persistent acute otitis media after initial amoxicillin failure 1
- Acute bacterial rhinosinusitis requiring enhanced coverage 1
The 14:1 formulation achieves 97-99% calculated bacteriologic efficacy against resistant pathogens 1.
Why the 7:1 Ratio is Less Relevant Now
The 7:1 ratio was an intermediate formulation. The 14:1 ratio (Augmentin ES-600) has largely replaced it because:
- It provides double the amoxicillin dose needed for resistant pneumococcus (90 mg/kg/day vs. 45 mg/kg/day)
- It maintains the same clavulanate dose as standard formulations, minimizing diarrhea risk
- The pediatric formulation provides a 14:1 ratio in oral suspension specifically designed for this purpose 1, 2
Common Pitfalls to Avoid
- Don't confuse tablet strengths with ratios: Two 250 mg tablets of amoxicillin-clavulanate are NOT equivalent to one 500 mg tablet, because both contain 125 mg of clavulanic acid 3
- Don't use standard-dose formulations for resistant infections: Standard dosing (40-45 mg/kg/day) has only 90-92% bacteriologic efficacy versus 97-99% for high-dose 1
- Don't exceed clavulanate limits: The clavulanate component limits maximum amoxicillin dosing due to GI side effects 1, 4
- Phenylketonuria warning: The ES-600 formulation contains 7 mg phenylalanine per 5 mL 2
Practical Prescribing
The FDA-approved high-dose pediatric formulation (Augmentin ES-600) delivers:
- 600 mg amoxicillin per 5 mL
- 42.9 mg clavulanate per 5 mL
- This creates the 14:1 ratio 2
Dosing is weight-based, given twice daily with food to enhance absorption and reduce GI upset 2.